The comparison of metronidazole and the combination of metronidazole and probitic on treatment of bacterial vaginosis
- Conditions
- Bactetial Vaginosis.Other specified inflammation of vagina and vulva
- Registration Number
- IRCT201106156807N1
- Lead Sponsor
- The Shahid Beheshti University of Medical Science & Health Service
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 90
1- bacterial vaginosis approval based on Amsel's criterias 2-married women aged 18-45 years 3-having one partner 4-absence of pregnancy and breast feeding 5-absence of mensturation at the time of attendance 6-not using vaginal drug, antibiotics and immonosupressive drugs since 14 days before starting the research 7-not having intercourse or using vaginal douche within the last 24 hours 8-absence of other types of candidias and trichmonas vaginitis at the time of study 9-not using alchohol , anticoagulant like comadin and disulfiram 10-absence of any diagnose medical disease such as diabetis , blood dyscrasia , thyroid disorders and liver disease by asking a patient 11-not using IUD. Exclusion criteria: 1-drug intolerancy 2-pregnancy during therapy 3-compulsion to use antibiotics
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Bactetial Vaginosis. Timepoint: Before treatment and after treatment. Method of measurement: Observation.
- Secondary Outcome Measures
Name Time Method Bactetial Vaginosis treatment. Timepoint: 3-7 days after treatment. Method of measurement: Observation.